Blockchain Registration Transaction Record

NeuroOne's OneRF Ablation Shows Promise in Drug-Resistant Epilepsy

NeuroOne Medical Technologies announces positive real-world results from 25 epilepsy patients treated with OneRF Ablation System at Mayo Clinic, showing reduced seizures and improved quality of life.

This news matters because drug-resistant epilepsy affects millions worldwide, and current treatment options often involve invasive surgery or lifelong medication with side effects. The OneRF Ablation System offers a minimally invasive, bedside procedure that can both diagnose and treat seizure foci in real time, potentially reducing hospitalizations, improving quality of life, and lowering healthcare costs. As the only FDA-cleared platform combining SEEG diagnosis and RF ablation, NeuroOne's technology could become a new standard of care, providing hope for patients who have exhausted other treatments.